Gerson regimen

Short peer-reviewed commentary by an oncology integrative-medicine specialist, confirmed via NCBI eutils directly. Notes advocates' claimed 'recovery rates of 70-90%' with neither the National Cancer Institute nor the New York County Medical Society finding supporting evidence, and draws a comparison to a National Cancer Institute-sponsored trial of an alternative pancreatic-cancer regimen in which standard chemotherapy patients survived substantially longer. Used for the claimed-recovery-rate figure and the general framing of unproven-regimen evaluation.